March 20, 2012 - MarBlue Medical announced the global product launch of its CE-marked drug-eluting balloon (DEB) Protege as well as its CoCr stent on DEB Pioneer. The full market launch of the new DEB technology is a major step forward in Blue Medical's quest to improve the quality of life of patients with cardiovascular diseases, while at the same time reducing procedure costs.

March 20, 2012 - GE Healthcare is demonstrating its new Centricity Cardio Enterprise solution during the American College of Cardiology (ACC) 2012 meeting in Chicago. The integrated cardiovascular clinical informatics system includes both CVIS (cardiovascular information system) and CPACS (cardiovascular picture archiving and communication system) functionality to provide clinicians full access to a single, comprehensive cardiovascular patient record. Centricity Cardio Enterprise features Web-enabled technology capable of driving workflow efficiencies and integrating with your current IT systems.

March 20, 2012 - DR Systems announced new contracts with four facilities for the company's Unity CVIS (Cardiovascular Information System). The facilities are: Twin Cities Community Hospital, Good Shepherd Medical Center, HealthCare Partners Medical Group and St. Luke's Cornwall Hospital.

March 19, 2012 - Cameron Health Inc. announced today that the U.S. Food and Drug Administration (FDA) Circulatory System Devices Panel will review the premarket approval (PMA) application of the S-ICD System on April 26, 2012.

There has been a convergence of expertise, deciding what is the best approach for patients and combining skill sets, imaging systems and tools of both interventionalists and surgeons, is the recent trend of hybrid ORs.
Bridgepoint StingRay and CrossBoss CTO catheters.
Terumo's FineCross guidewire to navigate CTOs.

Management of coronary chronic total occlusion (CTO) is individualized depending on the severity of symptoms, ischemia and on the severity of concomitant coronary artery disease (CAD). Treatment should include anti-anginal and other therapies to promote vascular health. Patients who remain symptomatic or have a large burden of ischemia despite maximal medical therapy can be considered for revascularization.

Cardiology departments have hosted a variety of software solutions in the past to meet varying demands. A recent report from KLAS reveals that the cardiology IT market is moving toward consolidation. The report, “Cardiology 2012: Will the Complete Cardiovascular Information System (CVIS) Please Stand Up?” explains a result of this consolidation trend is that providers are looking for a technology leader to step up and meet their needs.

Computer-aided detection (CAD) software constitutes a set of algorithms which, using a pattern-recognition technique, aids the radiologist in detecting potentially diseased regions and lesions. It uses clinical images obtained from various imaging modalities. CAD has long since left behind its branding as a mammography tool and has now widened its application areas, becoming a valuable tool for detection and diagnosis in cardiology.

March 19, 2012 – Individuals suffering from chronic heart failure (CHF) can look forward to the appearance of many new drug options over the next few years and place hope in a cure through future stem cell therapies, according to a new report by GlobalData.


While risk for sudden death is increased four- to six-fold in patients who have experienced myocardial infarction, it remains challenging to identify the specific patients who will benefit from the standard-of-care therapy, namely, implantation of an implantable cardioverter defibrillator (ICD).
Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now